I urge this committee to prioritize the safety and well-being of our communities, including the investments that we have put in improving public transit.

Mr. Chairman, I thank the ranking member for yielding. Mr. Chair, I rise today to speak in opposition to H.R. 1, the polluters over people act. I will take my time to point out two glaring flaws with this bill: First, H.R. 1 will make…

That would have a devastating impact on our workforce as well.

I think it was probably the most bipartisan vote we took.

Medicaid expansion has been an unqualified success. It has extended health insurance to millions of low-income people.

We need to continue to work with you because those authorities for flexibility on telehealth which you extended to the end of 2024, you can't have that cliff and all of a sudden have all those flexibilities expire.

The budget also reflects this administration's commitment to ending the mental health and substance use disorder crisis.

I am reintroducing my bipartisan bill, Increasing Transparency in Generic Drug Applications Act of 2022.

Site-neutral policies are also a tool to help strengthen the Medicare program overall.

Patients rely on supports like the 340B program, which provides discounts on essential prescription drugs to vulnerable communities.

I am proud to also co-lead this bill and look forward to discussing the legislation today.